NEWS

  • All
  • Corporate News
  • Media
All
  • All
  • Corporate News
  • Media
Corporate News

Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program

Read More
Corporate News

Mainz Biomed Expands European Commercial Footprint and Enters Markets in Spain and UK

Read More
Corporate News

Mainz Biomed Launches Corporate Health Program in Germany for ColoAlert

Read More
Media

Beyond Biotech Podcast: Mainz Biomed

Read More
Corporate News

Mainz Biomed Provides Year-End 2022 Corporate Review

Read More
Corporate News

Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert

Read More